Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOSAIC: Ivermectin and Brimonidine for Rosacea
NCT02616250Phase 4Completed
- Sponsor
- Galderma
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of ivermectin, brimonidine transdermal lotion in rosacea, sponsored by Galderma. Started Dec 2015; status: completed.
02
Drugs
ivermectinbrimonidine transdermal lotion
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT02616250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616250.